For example, Bhlhe40 facilitates PI3K/Akt/mTOR activation and triggers tumor progression in breast cancer, whereas it represses STAT1 expression and activates tumor suppression in clear cell carcinoma (Kiss et al., 2020). The gene discussed is BHLHE40; the disease is clear cell adenocarcinoma.